BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crescioli C, Sottili M, Bonini P, Cosmi L, Chiarugi P, Romagnani P, Vannelli GB, Colletti M, Isidori AM, Serio M, Lenzi A, Di Luigi L. Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur J Cell Biol 2012;91:139-49. [PMID: 22176919 DOI: 10.1016/j.ejcb.2011.09.011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The Immune System in Cushing's Syndrome. Trends Endocrinol Metab 2020;31:655-69. [PMID: 32387195 DOI: 10.1016/j.tem.2020.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
2 Crescioli C. Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy. Biomed Res Int 2014;2014:949730. [PMID: 24895631 DOI: 10.1155/2014/949730] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
3 Collignon C, Bol V, Chalon A, Surendran N, Morel S, van den Berg RA, Capone S, Bechtold V, Temmerman ST. Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys. Front Immunol 2020;11:579872. [PMID: 33329551 DOI: 10.3389/fimmu.2020.579872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vandanmagsar B, Haynie KR, Wicks SE, Bermudez EM, Mendoza TM, Ribnicky D, Cefalu WT, Mynatt RL. Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture. Diabetes Obes Metab 2014;16:728-38. [PMID: 24521217 DOI: 10.1111/dom.12274] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
5 Oda F, Uzawa A, Ozawa Y, Yasuda M, Kuwabara S. Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577833] [Reference Citation Analysis]
6 Afzali AM, Müntefering T, Wiendl H, Meuth SG, Ruck T. Skeletal muscle cells actively shape (auto)immune responses. Autoimmun Rev 2018;17:518-29. [PMID: 29526638 DOI: 10.1016/j.autrev.2017.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
7 Dunn A, Haas G, Madsen J, Ziemkiewicz N, Au J, Johnson D, West C, Chauvin H, Gagyi SM, Garg K. Biomimetic sponges improve functional muscle recovery following composite trauma. J Orthop Res 2021. [PMID: 34289186 DOI: 10.1002/jor.25143] [Reference Citation Analysis]
8 Antinozzi C, Marampon F, Sgrò P, Tombolini V, Lenzi A, Crescioli C, Di Luigi L. Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells. J Endocrinol Invest 2019;42:897-907. [PMID: 30600434 DOI: 10.1007/s40618-018-0998-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Scolletta S, Colletti M, Di Luigi L, Crescioli C. Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation. Mediators Inflamm 2013;2013:876319. [PMID: 23690671 DOI: 10.1155/2013/876319] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
10 Di Luigi L, Corinaldesi C, Colletti M, Scolletta S, Antinozzi C, Vannelli GB, Giannetta E, Gianfrilli D, Isidori AM, Migliaccio S, Poerio N, Fraziano M, Lenzi A, Crescioli C. Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation 2016;39:1238-52. [PMID: 27165639 DOI: 10.1007/s10753-016-0359-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
11 Antinozzi C, Sgrò P, Marampon F, Caporossi D, Del Galdo F, Dimauro I, Di Luigi L. Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts. Biology (Basel) 2021;10:491. [PMID: 34073032 DOI: 10.3390/biology10060491] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Corinaldesi C, Ross RL, Abignano G, Antinozzi C, Marampon F, di Luigi L, Buch MH, Riccieri V, Lenzi A, Crescioli C, Del Galdo F. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. Int J Mol Sci 2021;22:2894. [PMID: 33809279 DOI: 10.3390/ijms22062894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kim J, Choi JY, Park SH, Yang SH, Park JA, Shin K, Lee EY, Kawachi H, Kohsaka H, Song YW. Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse. Arthritis Res Ther 2014;16:R126. [PMID: 24939012 DOI: 10.1186/ar4583] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
14 Patel HP, Al-shanti N, Davies LC, Barton SJ, Grounds MD, Tellam RL, Stewart CE, Cooper C, Sayer AA. Lean Mass, Muscle Strength and Gene Expression in Community Dwelling Older Men: Findings from the Hertfordshire Sarcopenia Study (HSS). Calcif Tissue Int 2014;95:308-16. [DOI: 10.1007/s00223-014-9894-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
15 Sen CK, Khanna S, Harris H, Stewart R, Balch M, Heigel M, Teplitsky S, Gnyawali S, Rink C. Robot-assisted mechanical therapy attenuates stroke-induced limb skeletal muscle injury. FASEB J 2017;31:927-36. [PMID: 27895105 DOI: 10.1096/fj.201600437R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Mageriu V, Manole E, Bastian AE, Staniceanu F. Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies. J Immunol Res 2020;2020:9079083. [PMID: 32775472 DOI: 10.1155/2020/9079083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Di Luigi L, Sottili M, Antinozzi C, Vannelli GB, Romanelli F, Riccieri V, Valesini G, Lenzi A, Crescioli C. The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies. PLoS One 2013;8:e77745. [PMID: 24204948 DOI: 10.1371/journal.pone.0077745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
18 Crescioli C, Sturli N, Sottili M, Bonini P, Lenzi A, Di Luigi L. Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. J Endocrinol Invest 2013;36:1020-6. [PMID: 23873283 DOI: 10.3275/9034] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
19 Samant SA, Pillai VB, Gupta MP. Skeletal muscle-specific over-expression of the nuclear sirtuin SIRT6 blocks cancer-associated cachexia by regulating multiple targets. JCSM Rapid Commun 2021;4:40-56. [PMID: 34212132 DOI: 10.1002/rco2.27] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hyldahl RD, Olson T, Welling T, Groscost L, Parcell AC. Satellite cell activity is differentially affected by contraction mode in human muscle following a work-matched bout of exercise. Front Physiol 2014;5:485. [PMID: 25566087 DOI: 10.3389/fphys.2014.00485] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
21 Olazagasti JM, Niewold TB, Reed AM. Immunological Biomarkers in Dermatomyositis. Curr Rheumatol Rep 2015;17. [DOI: 10.1007/s11926-015-0543-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
22 Ishiuchi-Sato Y, Hiraiwa E, Shinozaki A, Nedachi T. The effects of glucose and fatty acids on CXCL10 expression in skeletal muscle cells. Biosci Biotechnol Biochem 2020;84:2448-57. [PMID: 32877316 DOI: 10.1080/09168451.2020.1814127] [Reference Citation Analysis]
23 Ceribelli A, De Santis M, Isailovic N, Gershwin ME, Selmi C. The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review. Clin Rev Allergy Immunol 2017;52:58-70. [PMID: 26780034 DOI: 10.1007/s12016-016-8527-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
24 Herzig DS, Luan L, Bohannon JK, Toliver-Kinsky TE, Guo Y, Sherwood ER. The role of CXCL10 in the pathogenesis of experimental septic shock. Crit Care 2014;18:R113. [PMID: 24890566 DOI: 10.1186/cc13902] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
25 Marampon F, Antinozzi C, Corinaldesi C, Vannelli GB, Sarchielli E, Migliaccio S, Di Luigi L, Lenzi A, Crescioli C. The phosphodiesterase 5 inhibitor tadalafil regulates lipidic homeostasis in human skeletal muscle cell metabolism. Endocrine 2018;59:602-13. [PMID: 28786077 DOI: 10.1007/s12020-017-1378-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
26 Bellutti Enders F, van Wijk F, Scholman R, Hofer M, Prakken BJ, van Royen-Kerkhof A, de Jager W. Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis. Arthritis Rheumatol 2014;66:2281-9. [PMID: 24756983 DOI: 10.1002/art.38676] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
27 Bartley JM, Pan SJ, Keilich SR, Hopkins JW, Al-Naggar IM, Kuchel GA, Haynes L. Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy. Aging (Albany NY) 2016;8:620-35. [PMID: 26856410 DOI: 10.18632/aging.100882] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
28 Lohachanakul J, Phuklia W, Thannagith M, Thongsakulprasert T, Smith DR, Ubol S. Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia: Viral Factor in CHIKV-Induced Myalgia. J Med Virol 2015;87:733-9. [DOI: 10.1002/jmv.24081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
29 Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools. Front Immunol 2018;9:2951. [PMID: 30619311 DOI: 10.3389/fimmu.2018.02951] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
30 Albayda J, Christopher-Stine L. Novel approaches in the treatment of myositis and myopathies. Ther Adv Musculoskelet Dis 2012;4:369-77. [PMID: 23024713 DOI: 10.1177/1759720X12447705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kennedy SA, Annett SL, Dunne MR, Boland F, O'Neill LM, Guinan EM, Doyle SL, Foley EK, Elliott JA, Murphy CF, Bennett AE, Carey M, Hillary D, Robson T, Reynolds JV, Hussey J, O'Sullivan J. Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors. Front Oncol 2021;11:669078. [PMID: 34604026 DOI: 10.3389/fonc.2021.669078] [Reference Citation Analysis]
32 Vasile M, Corinaldesi C, Antinozzi C, Crescioli C. Vitamin D in autoimmune rheumatic diseases: A view inside gender differences. Pharmacological Research 2017;117:228-41. [DOI: 10.1016/j.phrs.2016.12.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
33 Marzetti E, Picca A, Marini F, Biancolillo A, Coelho-junior HJ, Gervasoni J, Bossola M, Cesari M, Onder G, Landi F, Bernabei R, Calvani R. Inflammatory signatures in older persons with physical frailty and sarcopenia: The frailty “cytokinome” at its core. Experimental Gerontology 2019;122:129-38. [DOI: 10.1016/j.exger.2019.04.019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
34 Antinozzi C, Marampon F, Corinaldesi C, Vicini E, Sgrò P, Vannelli GB, Lenzi A, Crescioli C, Di Luigi L. Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells. J Endocrinol Invest 2017;40:1133-43. [PMID: 28508346 DOI: 10.1007/s40618-017-0686-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
35 Ouyang X, Zeng Y, Jiang X, Xu H, Ning Y. Identification of Vital Hub Genes and Potential Molecular Pathways of Dermatomyositis by Bioinformatics Analysis. Biomed Res Int 2021;2021:9991726. [PMID: 34580642 DOI: 10.1155/2021/9991726] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Venneri MA, Barbagallo F, Fiore D, De Gaetano R, Giannetta E, Sbardella E, Pozza C, Campolo F, Naro F, Lenzi A, Isidori AM. PDE5 Inhibition Stimulates Tie2-Expressing Monocytes and Angiopoietin-1 Restoring Angiogenic Homeostasis in Diabetes. The Journal of Clinical Endocrinology & Metabolism 2019;104:2623-36. [DOI: 10.1210/jc.2018-02525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
37 Romagnani P, Crescioli C. CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 2012;413:1364-73. [PMID: 22366165 DOI: 10.1016/j.cca.2012.02.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 7.2] [Reference Citation Analysis]
38 Erlandson KM, Jiang Y, Debanne SM, McComsey GA. Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy. AIDS Res Hum Retroviruses 2016;32:311-6. [PMID: 26477698 DOI: 10.1089/AID.2015.0191] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
39 Antinozzi C, Corinaldesi C, Giordano C, Pisano A, Cerbelli B, Migliaccio S, Di Luigi L, Stefanantoni K, Vannelli GB, Minisola S, Valesini G, Riccieri V, Lenzi A, Crescioli C. Potential role for the VDR agonist elocalcitol in metabolic control: Evidences in human skeletal muscle cells. J Steroid Biochem Mol Biol 2017;167:169-81. [PMID: 28042053 DOI: 10.1016/j.jsbmb.2016.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
40 Sottili M, Filardi T, Cantini G, Cosmi L, Morano S, Luconi M, Lenzi A, Crescioli C. Human cell-based anti-inflammatory effects of rosiglitazone. J Endocrinol Invest 2021. [PMID: 34170488 DOI: 10.1007/s40618-021-01621-5] [Reference Citation Analysis]
41 Lu X, Peng Q, Wang G. Discovery of new biomarkers of idiopathic inflammatory myopathy. Clinica Chimica Acta 2015;444:117-25. [DOI: 10.1016/j.cca.2015.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
42 Chandra T, Aggarwal R. Clinical trials and novel therapeutics in dermatomyositis. Expert Opin Emerg Drugs 2020;25:213-28. [PMID: 32597690 DOI: 10.1080/14728214.2020.1787985] [Reference Citation Analysis]
43 Deyhle MR, Gier AM, Evans KC, Eggett DL, Nelson WB, Parcell AC, Hyldahl RD. Skeletal Muscle Inflammation Following Repeated Bouts of Lengthening Contractions in Humans. Front Physiol 2015;6:424. [PMID: 26793125 DOI: 10.3389/fphys.2015.00424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
44 Deyhle MR, Hafen PS, Parmley J, Preece CN, Robison M, Sorensen JR, Jackson B, Eggett DL, Hancock CR, Hyldahl RD. CXCL10 increases in human skeletal muscle following damage but is not necessary for muscle regeneration. Physiol Rep 2018;6:e13689. [PMID: 29696819 DOI: 10.14814/phy2.13689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Catapano F, Scaglioni D, Maresh K, Ala P, Domingos J, Selby V, Ricotti V, Phillips L, Servais L, Seferian A, Groot I, Krom YD, Voit T, Verschuuren JJGM, Niks EH, Straub V, Morgan J, Muntoni F. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy. Epigenomics 2020;12:1899-915. [PMID: 33215544 DOI: 10.2217/epi-2020-0052] [Reference Citation Analysis]
46 Douglas J, Pearson S, Ross A, McGuigan M. Chronic Adaptations to Eccentric Training: A Systematic Review. Sports Med 2017;47:917-41. [PMID: 27647157 DOI: 10.1007/s40279-016-0628-4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 86] [Article Influence: 28.0] [Reference Citation Analysis]
47 Panimolle F, Tiberti C, Spaziani M, Riitano G, Lucania G, Anzuini A, Lenzi A, Gianfrilli D, Sorice M, Radicioni AF. Non-organ-specific autoimmunity in adult 47,XXY Klinefelter patients and higher-grade X-chromosome aneuploidies. Clin Exp Immunol 2021;205:316-25. [PMID: 33978253 DOI: 10.1111/cei.13616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Driscoll RK, Krasniewski LK, Cockey SG, Yang JH, Piao Y, Lehrmann E, Zhang Y, Michel M, Noh JH, Cui CY, Gorospe M. GRSF1 deficiency in skeletal muscle reduces endurance in aged mice. Aging (Albany NY) 2021;13:14557-70. [PMID: 34078750 DOI: 10.18632/aging.203151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Nasr R, Reed AM, Peterson EJ. Update: biomarkers for idiopathic inflammatory myopathies. Curr Opin Rheumatol 2012;24:609-15. [PMID: 23018857 DOI: 10.1097/BOR.0b013e3283585731] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
50 Mick PJ, Peng SA, Loftus JP. Serum Vitamin D Metabolites and CXCL10 Concentrations Associate With Survival in Dogs With Immune Mediated Disease. Front Vet Sci 2019;6:247. [PMID: 31417914 DOI: 10.3389/fvets.2019.00247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
51 Grzelkowska-Kowalczyk K, Wicik Z, Majewska A, Tokarska J, Grabiec K, Kozłowski M, Milewska M, Błaszczyk M. Transcriptional regulation of important cellular processes in skeletal myogenesis through interferon-γ. J Interferon Cytokine Res 2015;35:89-99. [PMID: 25237846 DOI: 10.1089/jir.2014.0018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
52 Croudace JE, Inman CF, Abbotts BE, Nagra S, Nunnick J, Mahendra P, Craddock C, Malladi R, Moss PA. Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. Blood 2012;120:4246-55. [PMID: 23012327 DOI: 10.1182/blood-2012-02-413260] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
53 Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Research Reviews 2017;35:200-21. [DOI: 10.1016/j.arr.2016.09.008] [Cited by in Crossref: 216] [Cited by in F6Publishing: 195] [Article Influence: 43.2] [Reference Citation Analysis]
54 Day J, Otto S, Proudman S, Hayball JD, Limaye V. Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies. Autoimmun Rev 2017;16:87-95. [PMID: 27666811 DOI: 10.1016/j.autrev.2016.09.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]